Biotecnología
Biotecnología
Peptone Expands Leadership Team with Key Executive Hires
29/09/2023 -
Patrik Foerch appointed chief scientific officer; David Lowe, senior vice president of protein therapeutics; and Benjamin Owens, chief business officer.
Chime, Panolos Partner to Advance Multi-specific Therapeutic Proteins
27/09/2023 -
Chime will provide development and manufacturing services to Panolos Bioscience for PB203.
Eminence Opens GMP Cell Culture Media Manufacturing Facility
13/09/2023 -
Aims to address the rapidly growing demand for high-quality media in the fields of vaccines, gene, cell therapies, antibodies, and recombinant proteins.
Colorcon Introduces TiO2-Free Moisture Protection Coating for Tablets
06/09/2023 -
Titanium dioxide free film coating designed to mitigate the challenges of moisture sensitive actives.
SomaLogic Expands Agreement with Novo Nordisk to 2025
06/09/2023 -
Novo Nordisk will extend its use of SomaLogic’s proteomics technologies in drug research and development.
Pfizer’s ABRYSVO for Infant RSV Prevention Approved in Pregnant Women
28/08/2023 -
First and only U.S. approval of a maternal vaccine to help protect infants at birth through six months of life from lower respiratory tract disease.
Astex, Merck Expand Drug Discovery Alliance
10/08/2023 -
Aims to identify small molecule candidates with activity towards a tumor suppressor protein for the treatment of cancer.
Cáñamo: una economía regional sostenible en gran crecimiento
09/08/2023 -
Contenido
La Transformación Digital: el impulso para el crecimiento de las PyMEs de Alimentos.
Cáñamo: una economía regional sostenible en...
iTolerance, Northway Biotech Partner on Manufacture of Streptavidin-FasL Fusion Protein
03/08/2023 -
Supports advancement of iTolerance's development of iTOL-100 towards first in human clinical study for lead program, iTOL-102.
Oramed, HTIT Create Joint Venture to Advance Oral Drug Delivery
03/08/2023 -
Will focus on innovative products using Oramed's oral insulin and protein oral delivery and HTIT's manufacturing capabilities and technologies.
Ginkgo Bioworks Awarded $18M DARPA Contract
28/07/2023 -
Ginkgo aims to deliver advances in on-demand protein manufacturing leveraging Cell-Free Protein Synthesis.
ABL Enters Seven-year Multimillion Dollar Contract with NIH
21/07/2023 -
Will support product development processes, documentation and production of customized recombinant proteins and monoclonal antibodies.
Qué está haciendo la FDA para proteger a los consumidores del cannabidiol (CBD) en los alimentos
30/06/2023 -
A Conversation with Douglas Stearn and Kristi Muldoon-Jacobs
The FDA has been receiving an increasing number of adverse reports about cannabidiol (CBD) containing products...
La FDA responde a tres avisos GRAS para ingredientes derivados de semillas de cáñamo para uso en alimentos para humanos
30/06/2023 -
La Administración de Drogas y Alimentos de EE. UU. ha completado su evaluación de tres avisos generalmente reconocidos como seguros (GRAS) para ingredientes alimentarios derivados de...
Curia Expands Cell Line Development Offering with CHOZN Platform
23/06/2023 -
Signs license agreement with MilliporeSigma to support production of proteins and antibodies.
Astellas, Cullgen Partner to Advance Targeted Protein Degraders
16/06/2023 -
To combine Cullgen's uSMITE targeted protein degradation platform featuring novel E3 ligands with Astellas' drug discovery capabilities.
ACROBiosystems Expands Custom GMP-grade Protein Services
08/06/2023 -
Move designed to support the commercialization of cell therapies.
MilliporeSigma Announces Proteologix as Winner of North American Biotech Grant
07/06/2023 -
Proteologix to receive in-kind products and services to develop treatments for autoimmune/inflammatory diseases and oncology indications.
Paraza Names Edward Marple Executive Vice President, Development
07/06/2023 -
Marple brings more than 20 years of experience as a senior executive with broad skill sets across clinical development, IP protection, and manufacturing.
TriLink BioTechnologies Unveils Latest mRNA Capping Technology
10/05/2023 -
Newest cap analog product improves mRNA potency with greater protein expression.
Amphista Therapeutics Attains First Discovery Milestone in BMS Alliance
05/05/2023 -
Under collaboration leveraging Amphista's next-gen targeted protein degradation platform, BMS is granted a global exclusive license to the resulting degraders.
